Tu1746 – A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderate to Severe Crohn's Disease
- Resource Type
- Abstract
- Source
- In
Gastroenterology May 2019 156(6) Supplement 1:S - Subject
- Language
- ISSN
- 0016-5085